Source study unconfirmed
Story checked
Antibiotic use from childhood linked to higher odds of IBS in young adulthood (opens in a new tab)
medicalxpress.com · 2026-10-18
Short answer
Source study unconfirmedNo confirmed study match.
We couldn’t confidently identify the source study behind this story. This leaves its claims unverified — not disproven.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
Antibiotic use from childhood linked to higher odds of IBS in young adulthood
medicalxpress.com · 2026-10-18
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
No single source study could be confirmed.
We could not identify a single source study for this article. It may discuss broader research or report findings from a source other than a research paper.
Open claim evidenceSearch result
Source study unconfirmed.
We could not identify a single source study for this article. It may discuss broader research or report findings from a source other than a research paper.
Source layer
The paper behind the story
The source record for this check.
The research anchor for the report.
- Also referencedpresented as the new finding
Antibiotic use from childhood and risk of adult irritable bowel syndrome: findings from a prospective birth cohort
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedAntibiotic use from childhood through early adulthood was associated with higher odds of irritable bowel syndrome (IBS) at age 24, with odds increasing as the number of antibiotic prescriptions rose, according to a new study presented at UEG Week 2026.View evidenceHide evidence
As statedhigher odds of IBS at age 24; increasing with more prescriptions
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 5Not checkedIn a population-based Swedish BAMSE birth cohort of 2,853 participants, 10.0% had IBS at age 24, and antibiotic use was more common among those with IBS than among those without IBS.View evidenceHide evidence
As stated10.0% had IBS; 87.8% vs 80.2% had received antibiotics
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 5Not checkedAfter adjustment for sex and family socioeconomic status, participants who had received antibiotics had 1.5 times the odds of IBS compared with those who had not, and the odds rose progressively with 1 to 2, 3 to 5, and 6 or more prescriptions.View evidenceHide evidence
As stated1.5x overall; 1.3x, 1.6x, and 1.7x across increasing prescription counts
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 5Not checkedTetracyclines and cephalosporins remained significantly associated with higher odds of IBS after adjustment, with any tetracycline use associated with 1.4 times the odds of IBS and three or more cephalosporin prescriptions associated with 6.0 times the odds.View evidenceHide evidence
As stated1.4x for tetracyclines; 6.0x for three or more cephalosporin prescriptions
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 5Not checkedLead author Dr. Jessica Sjölund said the study supports further research on a potential link between antibiotic exposure and IBS, but it does not establish causality.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Europe PMC, Crossref · 15 candidate papers
Pathogen and Testing Profiles in Post-Infectious Irritable Bowel Syndrome Across the COVID-19 Public Health Emergency: A Retrospective Case Series.
Journal of Clinical Medicine · 2026 · PubMed, Europe PMC
Probiotics and Antibiotics
Irritable Bowel Syndrome · 2024 · Crossref
Comorbidity Patterns in Patients with Atopic Dermatitis Using Network Analysis in the EpiChron Study.
2022 · Europe PMC
The Trajectory of Gastrointestinal Symptom Experience Following Fecal Microbiota Transplant for Recurrent Clostridioides Difficile Infection.
Journal of Clinical Gastroenterology · 2026 · PubMed
Diagnosis of irritable bowel syndrome
Irritable Bowel Syndrome · 1995 · Crossref